why choose us

First received: June 17, 2023

Clinical Trial: Endotype-Targeted Therapy to Rescue OSA Patients Struggling With CPAP Adherence (TOP-CPAP)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Obstructive Sleep Apnea

Study Type: INTERVENTIONAL


Official Title: Endotype-Targeted Therapy to Rescue OSA Patients Struggling With CPAP Adherence (TOP-CPAP): a Pilot Trial

Brief Summary: More than 10% of the US population have obstructive sleep apnea (OSA).Standard of care is therapy with CPAP (continuous positive airway pressure) which virtually eliminates OSA.However, most patients use CPAP only for part of the night (4-5hours) and about 50% patients discontinue CPAP long-term.Alternative therapies are limited, thus many OSA patients remain at risk of OSA sequelae (e.g.sleepiness, memory issues, high blood pressure, etc.).Importantly, different patients get OSA for different reasons, and recent…

Read more